This bill would devastate efforts to address the opioid crisis," said Dr. Joshua Sharfstein, director of the Bloomberg American Health Initiative at Johns Hopkins Bloomberg School of Public Health. " Thereâ€™s no question this legislation in the House of Representatives would cost American lives. " 